Millenium Biologix Announces FDA 510(k) Clearance for First Device Based on Microporous Skelite(TM) Technology
"This clearance allows us to bring our first product to market based on our Microporous Skelite Technology," said Dr. Timothy Smith, President and COO of Millenium. "This Microporous Skelite Technology enables the development of specialized synthetic bone graft implants with greater compressive strength and impact resistance. With these enhanced properties, the range of orthopedic applications for our Skelite technology has been broadened to include those where higher stresses are involved."
The Microporous Skelite Resorbable Cement Restrictor is a hollow, rounded rectangular device with textured surfaces on two opposing sides and is available in various sizes. It is packaged as a sterile, single use implantable device that is intended to be used as a cement restrictor in orthopedic surgeries such as those involving the femoral and tibial canals in hip stem and total knee replacements.
Most read news
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.